title: Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.
abstract: OBJECTIVE
  Low-grade non-Hodgkin's lymphoma (LGNHL) has traditionally been considered non-gallium-avid. The sensitivity of gallium 67 (67Ga) scintigraphy when using modern equipment and techniques in patients with LGNHL was investigated.
  
  
  METHODS
  Fifty-seven consecutive patients with LGNHL underwent 67Ga scintigraphy at initial presentation (n = 40), when tumor progression occurred during treatment (n = 3), and at suspected disease recurrence after continuous clinical remission (CCR) (n = 14). Planar and tomographic images were obtained with either a very large field-of-view or a dual-head digital camera. Of 45 patients with Ga-avid LGNHL, 30 underwent 93 follow-up scans (one to six studies per patient). Scan findings were correlated with clinical and computed tomographic (CT) findings and with patient outcomes.
  
  
  RESULTS
  67Ga scintigraphy was positive in 45 of 57 patients (sensitivity, 79%) and in 113 of 164 disease sites (sensitivity, 69%). The sensitivity was higher in the more common types of LGNHL: follicular, predominantly small cleaved cell (FSC), and follicular, mixed small cleaved and large cell (FM) (84% and 91% in patients and 72% and 71% in disease sites, respectively). Sensitivity was lower in patients with mucosa-associated lymphoid tissue lymphoma (MALT) and small lymphocytic lymphoma (SL). Among 28 patients with disease recurrence after CCR (14 with and 14 without baseline studies), 67Ga scan was positive in 25, for a sensitivity of 89% for detection of disease recurrence.
  
  
  CONCLUSIONS
  When modern technology is used, 67Ga scintigraphy has good sensitivity in patients with LGNHL. It therefore can be used to monitor response to therapy and to provide early detection of disease recurrence in these patients.
authors.affiliation: Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Ben-Haim
authors.forename: R
authors.initials: R
authors.lastname: Bar-Shalom
authors.forename: O
authors.initials: O
authors.lastname: Israel
authors.forename: N
authors.initials: N
authors.lastname: Haim
authors.forename: R
authors.initials: R
authors.lastname: Epelbaum
authors.forename: M
authors.initials: M
authors.lastname: Ben-Shachar
authors.forename: D
authors.initials: D
authors.lastname: Gaitini
authors.forename: G M
authors.initials: GM
authors.lastname: Kolodny
authors.forename: D
authors.initials: D
authors.lastname: Front
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005710:Gallium Radioisotopes; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D012008:Recurrence; D012680:Sensitivity and Specificity
chemical_list: D005710:Gallium Radioisotopes